Eight-Year Study of Childhood Status Epilepticus: Midazolam Infusion in Management and Outcome
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Sixty-eight children 2 months to 14 years of age were admitted with status epilepticus to Sultan Qaboos University Hospital from November 1993 to December 2001. Thirty-eight children (55.9%) had refractory status epilepticus and 30 (44.1%) had established status epilepticus. The children with refractory status epilepticus had received intravenous or per rectal diazepam and intravenous phenytoin/phenobarbital (either or both) before continuous infusion of midazolam was given. Fifty-one children received continuous midazolam infusion. In 38 children with refractory status epilepticus, the midazolam infusion was given in addition to the long-acting antiepilepsy drug, whereas 13 (18.8%) children needed only midazolam to control the established status epilepticus. Seventeen (25%) children were controlled with phenytoin sodium alone. Midazolam was given 0.15 mg/kg/minute initially as bolus in 1 minute, followed by 1 to 7 μgram/kg/minute as continuous infusion. The status could not be controlled in one child (1.5%) suffering from neurodegenerative disease. Two children needed mechanical ventilation following prolonged apnea after diazepam administration in one and diazepam plus phenobarbital in the other. No metabolic derangements or compromise of vital functions was noted on midazolam infusion. All children made a complete recovery. There was one death related to meningoencephalitis. ( J Child Neurol 2002;17:907—909).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Midazolam has also been found to be safe and effective when administered as a continuous infusion to treat refractory generalized convulsive status epilepticus (129-133).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [129]
Citations
Cites
Treiman, D. M. (1996) · PubMed · Cited by 1,024
Midazolam: pharmacology and uses.
Reves, J. G., Fragen, R. J., Vinik, H. R., & Greenblatt, D. J. (1985) · PubMed · Cited by 893
Verapamil: A Review of its Pharmacological Properties and Therapeutic Use1
Singh, B. N., Ellrodt, G., & Peter, C. T. (1978) · Drugs · doi:10.2165/00003495-197815030-00001 · Cited by 832
Midazolam: Pharmacology and Uses
Reves, J. G., Fragen, R. J., Vinik, H. R., & Greenblatt, D. J. (1985) · Anesthesiology · doi:10.1097/00000542-198503000-00017 · Cited by 742
(1993) · JAMA · doi:10.1001/jama.270.7.854 · Cited by 477
Low Morbidity and Mortality of Status Epilepticus in Children
Maytal, J., Shinnar, S., Moshé, S. L., & Alvarez, L. A. (1989) · Pediatrics · doi:10.1542/peds.83.3.323 · Cited by 468
Midazolam A Review of its Pharmacological Properties and Therapeutic Use
Dundee, J. W., Halliday, N. J., Harper, K. W., & Brogden, R. N. (1984) · Drugs · doi:10.2165/00003495-198428060-00002 · Cited by 359
Status epilepticus: epidemiologic considerations.
Hauser, W. A. (1990) · PubMed · Cited by 351
Midazolam: A review of therapeutic uses and toxicity
Nordt, S. P., & Clark, R. F. (1997) · The Journal of Emergency Medicine · doi:10.1016/s0736-4679(97)00022-x · Cited by 337
Status Epilepticus in Children, Adults, and the Elderly
DeLorenzo, R. J., Towne, A. R., Pellock, J. M., & Ko, D. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb06223.x · Cited by 250
Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus
Claassen, J., Hirsch, L. J., Emerson, R. G., Bates, J. E., Thompson, T. B., & Mayer, S. A. (2001) · Neurology · doi:10.1212/wnl.57.6.1036 · Cited by 220
Intravenous midazolam for the treatment of refractory status epilepticus
KUMAR, A., & BLECK, T. P. (1992) · Critical Care Medicine · doi:10.1097/00003246-199204000-00009 · Cited by 169
Intravenous Midazolam for the Treatment of Refractory Status Epilepticus
KUMAR, A., & BLECK, T. P. (1992) · Survey of Anesthesiology · doi:10.1097/00132586-199210000-00004 · Cited by 145
Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients
Venkataraman, V., & Wheless, J. W. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00005-4 · Cited by 128
Midazolam in the treatment of status epilepticus in children
RIVERA, R., SEGNINI, M., BALTODANO, A., & PÉREZ, V. (1993) · Critical Care Medicine · doi:10.1097/00003246-199307000-00011 · Cited by 120
Continuous midazolam infusion as treatment of status epilepticus
Koul, R. L., Aithala, G. R., Chacko, A., Joshi, R., & Elbualy, M. S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.76.5.445 · Cited by 99
Self-citationAdvances in the management of refractory status epilepticus
Bleck, T. P. (1993) · Critical Care Medicine · doi:10.1097/00003246-199307000-00004 · Cited by 78
Tonic clonic status epilepticus.
Shorvon, S. D. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.2.125 · Cited by 76
Midazolam and pentobarbital for refractory status epilepticus
Holmes, G. L., & Riviello, J. J. (1999) · Pediatric Neurology · doi:10.1016/s0887-8994(98)00155-6 · Cited by 71
Midazolam: an effective intravenous agent for seizure control.
Galvin, G. M., & Jelinek, G. A. (1987) · Archives of Emergency Medicine · doi:10.1136/emj.4.3.169 · Cited by 65
Intravenous Valproate Associated With Significant Hypotension in the Treatment of Status Epilepticus
White, J. R., & Santos, C. S. (1999) · Journal of Child Neurology · doi:10.1177/088307389901401211 · Cited by 49
Continuous infusion of midazolam hydrochloride to control status epilepticus.
Crisp, C. B., Gannon, R., & Knauft, F. (1988) · PubMed · Cited by 24
Minagawa, K., & Yanai, S. (1998) · PubMed · Cited by 10
Subtherapeutic free phenytoin levels following fosphenytoin therapy in status epilepticus
Koul, R. L., & Deleu, D. (2002) · Neurology · doi:10.1212/wnl.58.1.147 · Cited by 8
Self-citation
Research works printed but not linked: 6
- Hauser WA, 1990, Neurology, 40, 9
- Koul R., 2000, Neuroscience, 5, 13
- Crisp CB, 1988, Clin Pharm, 7, 322
- Egli M., 1981, Excerpta Medica, 137, 44
- Haefely W.: Benzodiazepine: Mechanism of action, in Levy R, Mattson R, Meldrum B, et al (eds): Antiepileptic Drugs , 3rd ed. New York, Raven Press, 1989, 721—734.
- Minagawa K., 1998, No To Hattatsu, 30, 290
Cited by
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Status epilepticus: pathophysiology and management in adults
Chen, J. W., & Wasterlain, C. G. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70374-x · Cited by 504
Shorvon, S., & Ferlisi, M. (2012) · Brain · doi:10.1093/brain/aws091 · Cited by 418
Outcome of paediatric convulsive status epilepticus: a systematic review
Raspall-Chaure, M., Chin, R. F., Neville, B. G., & Scott, R. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70546-4 · Cited by 297
Metadata
- Authors
- Koul, R., Chako, A., Javed, H., & Riyami, K. A.
- Affiliations
- Sultan Qaboos University Hospital (OM)
- Department of Child Health and Pharmacy Sultan Qaboos University Hospital Sultanate of Oman
- ORCID
- Koul, Roshan
- Venue
- Journal of Child Neurology
- Publisher
- SAGE Publications
- Published
- 2002-12
- Volume
- 17
- Issue
- 12
- Pages
- 907-909
- ISSN
- 0883-0738 (ISSN-L)
- 1708-8283
- OpenAlex
- W2169948844
- Cited by
- 53
- References
- 25
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 1 · 2022: 1 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 6 · 2013: 1 · 2012: 2
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Child Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Keywords
- status epilepticus, midazolam, continuous infusion, refractory status epilepticus, pediatric epilepsy, diazepam, phenytoin, phenobarbital, anticonvulsant therapy, treatment outcomes, meningoencephalitis
- MeSH terms
- Adolescent, Anticonvulsants, Child, Child, Preschool, Diazepam, Dose-Response Relationship, Drug, Electroencephalography, Female, Humans, Infant, Infusions, Intravenous, Injections, Intravenous, Male, Midazolam, Phenobarbital, Phenytoin, Status Epilepticus, Treatment Outcome, GABA Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.